CLINICAL-ASSESSMENT OF FLUORESCENCE CYSTOSCOPY DURING TRANSURETHRAL BLADDER RESECTION IN SUPERFICIAL BLADDER-CANCER

Citation
P. Jichlinski et al., CLINICAL-ASSESSMENT OF FLUORESCENCE CYSTOSCOPY DURING TRANSURETHRAL BLADDER RESECTION IN SUPERFICIAL BLADDER-CANCER, Urological research, 25, 1997, pp. 3-6
Citations number
17
Categorie Soggetti
Urology & Nephrology
Journal title
ISSN journal
03005623
Volume
25
Year of publication
1997
Supplement
1
Pages
3 - 6
Database
ISI
SICI code
0300-5623(1997)25:<3:COFCDT>2.0.ZU;2-N
Abstract
The prognosis of superficial bladder cancer in terms of recurrence and disease progression is related to bladder tumor multiplicity and the presence of concomitant ''plane'' tumors such as high-grade dysplasia and carcinoma in situ. This study in 33 patients aimed to demonstrate the role of fluorescence cystoscopy in transurethral resection of supe rficial bladder cancer. The method is based on the detection of protop orphyrin-IX-induced fluorescence in urothelial cancer cells by topical administration of 5-aminolevulinic acid. The sensitivity and the spec ificity of this procedure on apparently normal mucosa in superficial b ladder cancer are estimated to be 82.9% and 81.3%, respectively. Thus, fluorescence cytoscopy is a simple and reliable method for mapping th e bladder mucosa, especially in the case of multifocal bladder disease , and it facilitates the screening of occult dysplasia.